NEWS
All News
Special Reports
CONFERENCES
Conference Coverage
Conference Listing
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
PUBLICATIONS
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
CME/CE
RESOURCES
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
eNewsletter

logo
Featured Clinical Focus
AML
BTK Inhibitors: In-Focus
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
MPNs
Mantle Cell Lymphoma
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
Clinical Focus
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Spotlight
Case Based Peer Perspectives
Case-Based Roundtable Series
Clinical Trials
Podcasts
Precision Medicine
Special Reports
All News
Special Reports
Conference Coverage
Conference Listing
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
CME/CE
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
eNewsletter
Advertisement
BIOMARKER-DRIVEN LUNG CANCER
| BONE MARROW & STEM CELL TRANSPLANT
| GYNECOLOGIC CANCERS
| HEMATOLOGY
| LUNG CANCER
| SMALL CELL LUNG CANCER
| THYROID CANCERS
| BRAIN CANCER
| BREAST CANCER
| CAR T-CELL THERAPY
| ENDOMETRIAL CANCER
| GASTRIC CANCER
| GENITOURINARY CANCERS
| GENOMIC TESTING
| GI CANCERS
| HCC
| HEAD & NECK CANCERS
| IMMUNOTHERAPY
| LEUKEMIAS
| LYMPHOMAS
| MET-TARGETED THERAPY
| NTRK GENE FUSIONS
| SARCOMA
| SKIN CANCERS
View All >>
  • BIOMARKER-DRIVEN LUNG CANCER
  • BONE MARROW & STEM CELL TRANSPLANT
  • BRAIN CANCER
  • BREAST CANCER
  • CAR T-CELL THERAPY
  • ENDOMETRIAL CANCER
  • GASTRIC CANCER
  • GENITOURINARY CANCERS
  • GENOMIC TESTING
  • GI CANCERS
  • GYNECOLOGIC CANCERS
  • HCC
  • HEAD & NECK CANCERS
  • HEMATOLOGY
  • IMMUNOTHERAPY
  • LEUKEMIAS
  • LUNG CANCER
  • LYMPHOMAS
  • MET-TARGETED THERAPY
  • NTRK GENE FUSIONS
  • SARCOMA
  • SKIN CANCERS
  • SMALL CELL LUNG CANCER
  • THYROID CANCERS

SPOTLIGHT -

Case Based Peer Perspectives
| Case-Based Roundtable Series
| Clinical Trials
| Podcasts
| Precision Medicine
| Special Reports

Expanding Options for Relapsed/Refractory HER2+ Metastatic Breast Cancer

home / precision-medicine / expanding-options-for-relapsed-refractory-her2-metastatic-breast-cancer

Dr Mark Pegram and Dr Julie Gralow discuss treatment options in relapsed/refractory HER2+ metastatic breast cancer.


Treatment Options in HER2+ Metastatic Breast Cancer

EP. 1: Treatment Options in HER2+ Metastatic Breast Cancer

Targeted Oncology
July 7th 2020

Watch


Trastuzumab Emtansine in HER2+ Breast Cancer

EP. 2: Trastuzumab Emtansine in HER2+ Breast Cancer

Targeted Oncology
July 7th 2020

Watch


Options in Breast Cancer After HER2+ Targeted Therapy

EP. 3: Options in Breast Cancer After HER2+ Targeted Therapy

Targeted Oncology
July 7th 2020

Watch


Trastuzumab Deruxtecan in HER2+ Breast Cancer

EP. 4: Trastuzumab Deruxtecan in HER2+ Breast Cancer

Targeted Oncology
July 7th 2020

Watch


Neratinib + Capecitabine in HER2+ Breast Cancer

EP. 5: Neratinib + Capecitabine in HER2+ Breast Cancer

Targeted Oncology
July 7th 2020

Watch


Understanding HER2CLIMB Clinical Trial

EP. 6: Understanding HER2CLIMB Clinical Trial

Targeted Oncology
July 7th 2020

Watch


Toxicity Management When Using HER2CLIMB Regimen

EP. 7: Toxicity Management When Using HER2CLIMB Regimen

Targeted Oncology
July 7th 2020

Watch


Next-Generation Sequencing in HER2+ Breast Cancer

EP. 8: Next-Generation Sequencing in HER2+ Breast Cancer

Targeted Oncology
July 7th 2020

Watch


Newly Approved Agents for HER2+ Breast Cancer

EP. 9: Newly Approved Agents for HER2+ Breast Cancer

Targeted Oncology
July 7th 2020

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.